PanGen Biotech Inc (222110) — Financial Flexibility Index
PanGen Biotech Inc (222110) has a Financial Flexibility Index of -1.27x as of September 2025. Free cash flow of ₩-3.47 Billion (operating CF ₩-3.66 Billion minus capex ₩196.18 Million) represents -1% of total liabilities (₩2.74 Billion). Also explore PanGen Biotech Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PanGen Biotech Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for PanGen Biotech Inc across 11 annual periods. Check asset allocation strategy of PanGen Biotech Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for PanGen Biotech Inc (2014–2024)
Year-by-year free cash flow to debt coverage for PanGen Biotech Inc. For the full company profile including market capitalisation, see 222110 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | ₩3.36 Billion | ₩2.99 Billion | ₩5.64 Billion | ▲ +264.4% |
| 2023 | -0.36x | ₩-2.97 Billion | ₩-3.45 Billion | ₩8.18 Billion | ▲ +54.8% |
| 2022 | -0.80x | ₩-2.77 Billion | ₩-3.50 Billion | ₩3.45 Billion | ▼ -838.2% |
| 2021 | -0.09x | ₩-1.90 Billion | ₩-3.32 Billion | ₩22.18 Billion | ▲ +51.8% |
| 2020 | -0.18x | ₩-3.93 Billion | ₩-4.68 Billion | ₩22.10 Billion | ▼ -29.1% |
| 2019 | -0.14x | ₩-2.84 Billion | ₩-3.66 Billion | ₩20.66 Billion | ▲ +43.6% |
| 2018 | -0.24x | ₩-4.55 Billion | ₩-5.61 Billion | ₩18.67 Billion | ▼ -172.6% |
| 2017 | 0.34x | ₩1.44 Billion | ₩-657.84 Million | ₩4.28 Billion | ▲ +179.8% |
| 2016 | -0.42x | ₩-880.81 Million | ₩-4.35 Billion | ₩2.09 Billion | ▼ -15542.4% |
| 2015 | 0.00x | ₩-25.14 Million | ₩-1.61 Billion | ₩9.34 Billion | ▲ +97.9% |
| 2014 | -0.13x | ₩-792.03 Million | ₩-1.34 Billion | ₩6.18 Billion | — |